StockData
TRXBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

TRex Bio, Inc.

$14.80+0.79 (+5.64%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

TRex Bio has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements TRex Bio filed with the SEC